科研之友
微信
新浪微博
Facebook
分享链接
摘要
BackgroundMicroRNA-214 (miR-214) expression has been demonstrated to be dysregulated in human malignancies and to play various roles in tumor progression. While previous study of miRNA expression profiling found that it was one of the most upregulated miRNAs in osteosarcoma signature, the potential role of miR-214 in osteosarcomas has been unclear. Therefore, the aim of this study was to investigate association of miR-214 expression with clinicopathologic features and prognosis in pediatric patients with osteosarcoma. ProcedureQuantitative real-time reverse transcriptase-polymerase chain reaction analysis was performed to detect expression levels of miR-214 in cancerous and noncancerous bone tissues from 92 children treated for primary osteosarcomas. Then, the clinical significance of miR-214 dysregulation in pediatric osteosarcomas was also determined. ResultsCompared with noncancerous bone tissues, the expression levels of miR-214 were significantly upregulated in osteosarcoma tissues (P<0.001). High miR-214 expression occurred more frequently in osteosarcoma tissues with large tumor size (P=0.01), positive metastasis (P=0.001) and poor response to pre-operative chemotherapy (P=0.006). Moreover, high miR-214 expression was significantly associated with both shorter overall (P<0.001) and progression-free survival (PFS; P=0.001). Multivariate analysis by the Cox proportional hazard model further confirmed that high miR-214 expression was an independent prognostic factor of unfavorable survival in pediatric osteosarcoma (for overall survival: P=0.008; for PFS: P=0.01). ConclusionOur data offer evidence that upregulated expression of miR-214 may be linked to tumor progression and adverse prognosis in pediatric osteosarcoma. Further investigation in prospective studies would appear warranted. Pediatr Blood Cancer 2014;61:206-210.
